E. S. Venkatraman

6.0k citations

41 papers · 4.1k indexed · 2 hit papers · h-index 21

Molecular Biology top 5%
Genetics top 1%
Cancer Research top 2%
Oncology top 5%
Pulmonary and Respiratory Medicine top 5%

Co-authors: Adam B. Olshen Michael Wigler David Siegmund Valerie W. Rusch David S. Klimstra Colin B. Begg Amreen Husain Gang He
Topics: Ovarian cancer diagnosis and treatment (9 papers)Intraperitoneal and Appendiceal Malignancies (8 papers)Lung Cancer Diagnosis and Treatment (7 papers)
Cited by: Cancer Research Genetics Reproductive Medicine
Journals: Journal of Clinical Oncology Bioinformatics Biometrics
Partner nations: United States Ireland United Kingdom

In The Last Decade

E. S. Venkatraman

40 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Circular binary segmentation for the analysis of array-based DNA copy number data

2004 1.5k citations Adam B. Olshen, E. S. Venkatraman et al. Biostatistics profile →
A faster circular binary segmentation algorithm for the analysis of array CGH data

2007 621 citations E. S. Venkatraman, Adam B. Olshen Bioinformatics profile →

Peers

Countries citing papers authored by E. S. Venkatraman

Since Specialization

Citations

This map shows the geographic impact of E. S. Venkatraman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. S. Venkatraman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. S. Venkatraman more than expected).

Fields of papers citing papers by E. S. Venkatraman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. S. Venkatraman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. S. Venkatraman. The network helps show where E. S. Venkatraman may publish in the future.

Co-authorship network of co-authors of E. S. Venkatraman

This figure shows the co-authorship network connecting the top 25 collaborators of E. S. Venkatraman. A scholar is included among the top collaborators of E. S. Venkatraman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. S. Venkatraman. E. S. Venkatraman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	D2-01: Prospective trial of preoperative gefitinib to correlate response with EGFR exon 19 and 21 mutations and to select patients for adjuvant gefitinib 2007 ·Journal of Thoracic Oncology ·Mark G. Kris,William Pao,Maureen F. Zakowski,Marc Ladanyi,Robert T. Heelan,Lawrence B. Schwartz,B. Zhao,E. S. Venkatraman,Valerie W. Rusch,Naiyer A. Rizvi	1
2	A faster circular binary segmentation algorithm for the analysis of array CGH databreakdown → 2007 ·Bioinformatics ·E. S. Venkatraman,Adam B. Olshen	621
3	A phase I study evaluating the safety and pharmacokinetics of weekly paclitaxel and carboplatin in relapsed ovarian cancer 2007 ·International Journal of Gynecological Cancer ·Aliza Leiser,Fernando Cotait Maluf,D. S.,Paul Sabbatini,Martee L. Hensley,Lawrence H. Schwartz,E. S. Venkatraman,D. Spriggs,Carol Aghajanian	13
4	Topotecan and liposomal doxorubicin in recurrent ovarian cancer: is sequence important? 2006 ·International Journal of Gynecological Cancer ·Jakob Dupont,Carol Aghajanian,(unknown),Meghan Lovegren,Shaokun Chuai,E. S. Venkatraman,Martee L. Hensley,Sibyl Anderson,David R. Spriggs,Paul Sabbatini	6
5	Properties of analysis methods that account for clustering in volume–outcome studies when the primary predictor is cluster size 2006 ·Statistics in Medicine ·Katherine S. Panageas,Deborah Schrag,A. Russell Localio,E. S. Venkatraman,Colin B. Begg	35
6	Prospective trial with preoperative gefitinib to correlate lung cancer response with EGFR exon 19 and 21 mutations and to select patients for adjuvant therapy 2006 ·Journal of Clinical Oncology ·Mark G. Kris,William Pao,(unknown),Marc Ladanyi,R T Heelan,Lawrence B. Schwartz,B. Zhao,E. S. Venkatraman,Valerie W. Rusch,Naiyer A. Rizvi	10
7	Two‐Stage Designs for Gene–Disease Association Studies with Sample Size Constraints 2004 ·Biometrics ·Jaya M. Satagopan,E. S. Venkatraman,Colin B. Begg	97
8	Circular binary segmentation for the analysis of array-based DNA copy number databreakdown → 2004 ·Biostatistics ·Adam B. Olshen,E. S. Venkatraman,(unknown),Michael Wigler	1495
9	Two‐Stage Designs for Gene–Disease Association Studies 2002 ·Biometrics ·Jaya M. Satagopan,David Verbel,E. S. Venkatraman,Kenneth Offit,Colin B. Begg	90
10	Paclitaxel-Based Chemotherapy in Carcinoma of the Fallopian Tube 2001 ·Gynecologic Oncology ·Mary L. Gemignani,Martee L. Hensley,Rose S. Cohen,E. S. Venkatraman,Patricia E. Saigo,Richard R. Barakat	37
11	A Permutation Test to Compare Receiver Operating Characteristic Curves 2000 ·Biometrics ·E. S. Venkatraman	124
12	Intraperitoneal Cisplatin and Intravenous Paclitaxel in the Treatment of Epithelial Ovarian Cancer Patients with a Positive Second Look 2000 ·Gynecologic Oncology ·Sharmila Makhija,Paul Sabbatini,Carol Aghajanian,E. S. Venkatraman,David R. Spriggs,R. Barakat	7
13	Properties of A Nonparametric Test for Early Comparison of Treatments in Clinical Trials in the Presence of Surrogate Endpoints 1999 ·Biometrics ·E. S. Venkatraman,Colin B. Begg	9
14	Phase II Trial of Intraperitoneal Cisplatin and Mitoxantrone in Patients with Persistent Ovarian Cancer 1999 ·Gynecologic Oncology ·Amreen Husain,Paul Sabbatini,David R. Spriggs,D. Fennelly,Carol Aghajanian,R. Barakat,John P. Curtin,E. S. Venkatraman,William J. Hoskins,Maurie Markman	17
15	A Phase II Trial of Intraperitoneal Cisplatin and Etoposide as Consolidation Therapy in Patients with Stage II–IV Epithelial Ovarian Cancer Following Negative Surgical Assessment 1998 ·Gynecologic Oncology ·Richard R. Barakat,Lois Almadrones,E. S. Venkatraman,Carol Aghajanian,(unknown),Fred Shapiro,John P. Curtin,David R. Spriggs	66
16	BRCA1 up-regulation is associated with repair-mediated resistance to cis-diamminedichloroplatinum(II). 1998 ·PubMed ·Amreen Husain,Gang He,E. S. Venkatraman,D R Spriggs	233
17	Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer. 1998 ·Journal of Clinical Oncology ·Carol Aghajanian,D. Fennelly,F.L. Shapiro,Roger J. Waltzman,Lois Almadrones,C O'Flaherty,(unknown),E. S. Venkatraman,R. Barakat,John P. Curtin,(unknown),Lillian Reich,David Wuest,Larry Norton,W.J. Hoskins,David R. Spriggs	39
18	The Role of Surgical Cytoreduction in Stage IV Endometrial Carcinoma 1997 ·Gynecologic Oncology ·S. Dennis,(unknown),E. S. Venkatraman,Richard R. Barakat	92
19	Hepatic Resection for Metastatic Gynecologic Carcinomas 1997 ·Gynecologic Oncology ·S. Dennis,Yuman Fong,E. S. Venkatraman,R.R. Barakat	50
20	Molecular Markers Help Characterize Neuroendocrine Lung Tumors 1996 ·The Annals of Thoracic Surgery ·Valerie W. Rusch,David S. Klimstra,E. S. Venkatraman	98

About E. S. Venkatraman

E. S. Venkatraman is a scholar working on Reproductive Medicine, Statistics and Probability and Obstetrics and Gynecology, having authored 41 papers that have together received 4.1k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (9 papers), Intraperitoneal and Appendiceal Malignancies (8 papers) and Lung Cancer Diagnosis and Treatment (7 papers). The work is most often cited by research in Cancer Research (922 citations), Genetics (1.4k citations) and Reproductive Medicine (362 citations). E. S. Venkatraman has collaborated with scholars based in United States, Ireland and United Kingdom. Frequent co-authors include Adam B. Olshen, Michael Wigler, David Siegmund, Valerie W. Rusch, David S. Klimstra, Colin B. Begg, Amreen Husain, Gang He, D R Spriggs and Peter W. T. Pisters. Their work appears in journals such as Journal of Clinical Oncology, Bioinformatics and Biometrics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact